DYSLIPIDEMIA IN TYPE 2 DIABETES MELLITUSDYSLIPIDEMIA IN TYPE 2 DIABETES MELLITUS

Journal Title: Acta HealthMedica - Year 2018, Vol 3, Issue 1

Abstract

Background: Dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL- cholesterol particles. The objective of this work was to define and characterize the lipid profile of type 2 diabetic patients Methods: A series of 30 patients was selected for the study of the lipid profile; the classic methods were used for the determination of triglycerides, total cholesterol, C-HDL, and C-LDL. Results: According to our results, all our patients had hyperglycemia, our patients had a body weight ≥ 80 kg, with an overweight of 88% in women and 86.4% in men. All our patients had dyslipidemia with high levels of triglycerides and total cholesterol. Conclusion: Lipid abnormalities are part of the metabolic disease and contribute to the increased cardiovascular risk of type 2 diabetes, intensive treatment of dyslipidemia becomes an absolute obligation in the cardiovascular prevention of these patients.

Authors and Affiliations

Youb Imane, Missoun Fatiha, Karamane souad, Bouabedelli Fatma, Benhamimed El attafia, Djebli Noureddine

Keywords

Related Articles

SINGLE AUTHOR PAPERS IN MASHHAD UNIVERSITY OF MEDICAL SCIENCES (MUMS) IN THE RECENT 10 YEARS

Introduction: Bibliometric analysis can explore the patterns of authorship. The single authorship is an unpleasant phenomenon in research, and we investigate the single author papers’ trend in Mashhad University of Medic...

PERSIAN REGISTRY OF CARDIOVASCULAR DISEASE (PROVE)

Introduction: The Persian Registry Of cardioVascular diseasE (PROVE) aimed to study the demographic, clinical, diagnosis and treatment of patients with cardiovascular disease (CVD) and to follow them for 1 to 3 years, l...

GENETIC EPIDEMIOLOGICAL CHARACTERIZATION OF THE POPULATION OF TLEMCEN (WEST ALGERIA) BY TYPE 1 DIABETES

Background: Type 1 diabetes is a real public health problem, concerning not only its complications and cost, but also its increasing incidence and the fact that it occurs in young people. The objective of this study is t...

FASA REGISTRY FOR SYSTOLIC HEART FAILURE (FARSH), FEASIBILITY STUDY

Background: Systolic heart failure (SHF), as a highly prevalent disease with serious costs to the health system, is becoming one of the major challenges for health policy makers. Every attempt to define treatment pattern...

EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN PREVENTION OF PRETERM NEONATAL SEPSIS: A CLINICAL TRIAL STUDY

Background: The incidence of severe sepsis and septic shock is higher among preterm infants. Prevention of neonatal sepsis has remained a global challenge in recent decades. The role of intravenous immunoglobulin (IVIG)...

Download PDF file
  • EP ID EP345035
  • DOI 10.19082/ah236
  • Views 123
  • Downloads 0

How To Cite

Youb Imane, Missoun Fatiha, Karamane souad, Bouabedelli Fatma, Benhamimed El attafia, Djebli Noureddine (2018). DYSLIPIDEMIA IN TYPE 2 DIABETES MELLITUSDYSLIPIDEMIA IN TYPE 2 DIABETES MELLITUS. Acta HealthMedica, 3(1), 236-236. https://europub.co.uk/articles/-A-345035